CARE vs HBAN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
CARE
HBAN
Investment Advisor Scores
HBAN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CARE | HBAN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.6612 | 8.6957 | HBAN |
| PEG Ratio | 0 | 1.8503 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.1% | 32.2% | HBAN |
| Earnings Growth | 45.8% | -19.5% | CARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 53.2/100 | 47.6/100 | CARE |
| Profit Margin | 45.7% | 25.4% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | CARE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CARE
MarkdownPrice below a falling SMA50 (slope -2.9%), weak momentum, RSI 44
HBAN
NeutralMixed signals - no dominant trend phase, RSI 53
Fundamentals Snapshot
| Metric | CARE | HBAN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.7 | 9.1 |
| Trailing P/E | 5.0 | 13.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.3% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.2% | 0.4% |
| EPS | 5.91 | 1.22 |
| Dividend Yield | 0.01% | 0.04% |